IP Library Granted Patent US 9,903,830
Granted Patent B2
US 9,903,830 · App. 14/353,870 · Granted Feb 27, 2018

Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte

Inventors: Michael Malecha (Muir of Ord, GB); Antony Smith (Inverness-shire, GB); David McColl (Inverness-shire, GB)
Assignee: LifeScan Scotland Limited
G01N27/3274G01N27/26G01N27/3272G06F19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,903,830
App. No.
14/353,870
Filed
Apr 24, 2014
Granted
Feb 27, 2018
Kind
B2
Art Unit
1798
USPC
205/777.5
Abstract

Various embodiments for methods and systems that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic of the sample containing the analyte and deriving one of a batch slope, sampling time, or combinations thereof to attain accurate glucose concentration.

Claims (46)

1. A method of demonstrating increased accuracy of a test strip, the method comprising:

providing a batch of test strips;

introducing a referential sample containing a referential concentration of an analyte to each test strip of the batch of test strips to initiate a test sequence;

reacting the analyte with a reagent on each test strip to cause a physical transformation of the analyte;

determining a physical characteristic of the referential sample;

deriving a defined batch slope for the batch of test strips based on the determined physical characteristics of the referential sample for selected test strips from the batch of test strips;

determining an approximate analyte concentration of the referential analyte concentration as being in one of a low glucose range, a medium glucose range or a high glucose range;

determining a sampling time point based on the approximate analyte concentration of the referential analyte concentration, the determined sampling time point being selected as a first sampling time point responsive to the approximate analyte concentration being in the low glucose range, a second sampling time point responsive to the approximate analyte concentration being in the medium glucose range, and a third sampling time point responsive to the approximate analyte concentration being in the high glucose range;

sampling an electrical output of the referential sample at the determined sampling time point during the test sequence;

calculating an analyte concentration based on the defined batch slope, the determined sampling time point and sampled electrical output to provide for a final analyte concentration value for each test strip of the batch of test strips such that at least 95% of the final analyte concentration values of the batch of test strips are within ±15% of the referential analyte concentration.

2. The method of claim 1 , in which the determining comprises applying a first signal to the sample to measure the physical characteristic of the sample.

3. The method of claim 2 , in which the sampling comprises driving a second signal to the sample.

4. The method of claim 3 , in which the applying of the first signal and the driving of the second signal is in sequential order.

5. The method of claim 3 , in which the applying of the first signal overlaps with the driving of the second signal.

6. The method of claim 2 , in which the applying of the first signal comprises directing an optical signal to the sample so that a physical characteristic of the sample is determined from an output of the optical signal.

7. The method of claim 2 , in which the applying of the first signal comprises directing an alternating signal to the sample so that a physical characteristic of the sample is determined from an output of the alternating signal.

8. The method of claim 2 , in which the applying of the first signal comprises driving first and second alternating signals at different respective frequencies in which a first frequency is lower than the second frequency.

9. The method of claim 8 , in which the first frequency is at least one order of magnitude lower than the second frequency.

10. The method of claim 8 , in which the first frequency comprises any frequency in the range of about 10 kHz to about 250 kHz.

11. The method of claim 1 , in which the physical characteristic comprises at least one of viscosity, hematocrit, temperature, and density of the sample, or combinations thereof.

12. The method of claim 1 , in which the physical characteristic comprises hematocrit and the analyte comprises glucose.

13. The method of claim 1 , in which the deriving comprises calculating a batch slope from an equation of the form:

x=aH 2 +bH+c

where

x represents a derived batch slope from the deriving step;

H represents the measured, determined or estimated physical characteristic of the sample;

a represents about 1.4e−6,

b represents about −3.8e−4,

c represents about 3.6e−2.

14. The method of claim 13 , in which the calculating of the analyte concentration comprises utilizing an equation of the form:

G

0

=

[

I

E

-

Intercept

x

]

where

G 0 represents an analyte concentration

I E represents, or is, a signal (value or measurement; proportional to analyte concentration) measured at a predetermined or specified sampling time;

Intercept represents a calibration parameter for a batch of biosensors;

x represents a derived batch slope from the deriving step.

15. The method of claim 14 , in which the predetermined time is about 2.5 seconds after a start of the test sequence.

Assignments (7)
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: MALECHA, MICHAEL; SMITH, ANTONY; MCCOLL, DAVID
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 044627/0700 →
Continuity (6)
Provisional Application 61581087 · Dec 29, 2011
Provisional Application 61581089 · Dec 29, 2011
Provisional Application 61581099 · Dec 29, 2011
Provisional Application 61581100 · Dec 29, 2011
Provisional Application 61654013 · May 31, 2012
Related Publication 20140332408A1 · Nov 13, 2014